Propoven 2% May Join Your Sedative List Due to COVID-19
A new double-strength propofol may hit your shelves...to help meet demand during the COVID-19 pandemic.
It’s because more patients are requiring sedation due to mechanical ventilation for COVID-19...and regular propofol and other sedatives (midazolam, etc) have been in short supply.
“Double-strength” means the product is propofol 2%, or 20 mg/mL...compared to regular propofol, which is 1%, or 10 mg/mL.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote